Table 6.

Summary of Wound Assessment Parameters

	Meloxicam IV (n=283)	Placebo (n=96)
Investigator Satisfaction with Surgical Wound Healing*
LSD + 1/Discharge	9.6 ± 0.69	9.5 ± 0.86
LSD + 7 days	9.4 ± 1.01	9.4 ± 0.89
Clinically Significant Wound Assessment Parameters, n (%)
Erythema	3 (1.1)	1 (1.1)
Drainage	1 (0.4)	1 (1.1)
Edema	1 (0.4)	0
Induration	1 (0.4)	0
Hematoma	1 (0.4)	0

Note: *11-point scale with 0 = “completely unsatisfied” and 10 = “completely satisfied.”

Abbreviations: IV, intravenous; LSD, last study dose.